.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Primar Univ. Doz. Dr. Harald Schennach

Chair

22/09/2022
15:30 – 16:30
Vortragssitzung
Hämotherapie
Franz Xaver Richter

Further involvements

22/09/2022
16:40 – 16:45 3 Min. 2 Min.
Poster
PS-5-5
Meeting the demands for bone allografts: challenges during COVID-19 pandemic
14. Gewebezubereitungen, 16. Rechtliche Grundlagen, Qualitätssicherung und regulatorische Aspekte
22/09/2022
16:55 – 17:00 3 Min. 2 Min.
Poster
PS-5-8
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies between June 2020 and April 2022 in Tyrolean blood donors
19. COVID-19, 5. Infektionssicherheit von Blutprodukten
23/09/2022
09:50 – 10:00 6 Min. 4 Min.
Abstractvortrag
VS-21-9
Upregulation of check-point ligand PD-L1 in patients with PNH explained by proximal complement activation
7. Immunhämatologie und Immunologische Grundlagen, 9. Hämotherapie